- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 513/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 513/14
Total number of patents in this class: 462
10-year publication summary
|
33
|
26
|
27
|
26
|
42
|
44
|
41
|
40
|
33
|
12
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
21 |
| Merck Patent GmbH | 5909 |
18 |
| Agios Pharmaceuticals, Inc | 200 |
15 |
| Newave Pharmaceutical Inc. | 54 |
12 |
| Senhwa Biosciences, Inc. | 44 |
11 |
| BASF SE | 19740 |
9 |
| Janssen Pharmaceutica N.V. | 3839 |
9 |
| Rigel Pharmaceuticals, Inc. | 613 |
8 |
| Shionogi & Co., Ltd. | 914 |
8 |
| Novartis AG | 11238 |
7 |
| Abbvie Inc. | 1808 |
7 |
| Millennium Pharmaceuticals, Inc. | 488 |
7 |
| Genentech, Inc. | 3742 |
6 |
| Istituto Nazionale di Genetica Molecolare-ingm | 24 |
6 |
| Janssen Sciences Ireland UC | 256 |
6 |
| Ospedale San Raffaele S.r.l. | 240 |
6 |
| Irbm S.p.A. | 19 |
6 |
| Pfizer Inc. | 3322 |
5 |
| Georgia Tech Research Corporation | 2453 |
5 |
| University of Florida Research Foundation, Inc. | 3883 |
5 |
| Other owners | 285 |